Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
ONSIW was delisted on the 3rd of December, 2018.
7 hedge funds and large institutions have $1.96M invested in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.
304% more capital invested
Capital invested by funds: $484K → $1.96M (+$1.47M)
36% less funds holding
Funds holding: 11 → 7 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$82.2K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$24K |
| 3 |
JG
Jefferies Group
New York
|
-$15K |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$10.6K |
| 5 |
Morgan Stanley
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $763K | – | – | – |
|
|
PA
2
Perceptive Advisors
New York
| $370K | -$82.2K | -193,882 | -30% |
|
|
CAM
3
Cormorant Asset Management
Boston,
Massachusetts
| $333K | – | – | – |
|
|
ACA
4
Avoro Capital Advisors
New York
| $187K | – | – | – |
|
|
MWNA
5
Marshall Wace North America
New York
| $125K | +$53K | +125,100 | New |
|
|
PC
6
PointState Capital
New York
| $80K | – | – | – |
|
|
ACP
7
Acuta Capital Partners
Redwood City,
California
| $77K | – | – | – |
|
|
MIM
8
Monashee Investment Management
Boston,
Massachusetts
| $20K | -$10.6K | -25,000 | Closed |
|
|
9
Marshall Wace
London,
United Kingdom
| – | -$24K | -125,100 | Closed |
|
|
JG
10
Jefferies Group
New York
| – | -$15K | -79,347 | Closed |
|
|
11
Morgan Stanley
New York
| – | -$2K | -8,950 | Closed |
|
ONSIW Hedge Fund Activity: Q1 2017 in Review
7 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) for Q1 2017, worth a combined $1.96M — up 304% from $484K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ONSIW and 1 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Perceptive Advisors, cutting an estimated $82.2K.
- 7 institutional investors held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) as of Q1 2017, down from 11 in Q4 2016.
- Funds reported $1.96M of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 stock for Q1 2017, up 304% quarter-over-quarter.
- 1 fund opened new Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 positions in Q1 2017 and 5 closed out, a net change of -4 holders.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 seller in Q1 2017 was Perceptive Advisors, an estimated $82.2K sold.
Based on aggregated 13F filings for Q1 2017.